1 company and 1 research report found for "Ascendis Pharma"
No sector reports have been found.
With a January 2015 IPO and December 2014 mezzanine funding raising a total c $170m, Ascendis now has breathing space to develop its pipeline. TransCo...
Forgotten your login?
Registered office: Edison Investment Research Limited, 280 High Holborn, London, WC1V 7EE UK. Company no. 4794244. VAT no. 815041270
© 2017 All rights reserved. Edison Investment Research is authorised and regulated by the Financial Conduct Authority.
This site requires cookies in order to give you the best user experience.
Find out more